Middle East Healthcare Company (TADAWUL:4009)
31.10
-0.90 (-2.81%)
At close: Mar 9, 2026
TADAWUL:4009 Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 301.88 | 282 | 17.04 | 75.18 | 17.2 | Upgrade
|
| Depreciation & Amortization | - | 206.18 | 187.09 | 144.46 | 140.03 | Upgrade
|
| Other Amortization | - | 10.57 | 2.72 | 1.52 | 1.38 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -19.06 | 0.76 | 1.98 | 1.68 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | -45.45 | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | - | 0.52 | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | -29.05 | 32.07 | 1.57 | -13.74 | Upgrade
|
| Other Operating Activities | 242.72 | 253.64 | 306.06 | 79.9 | 51.3 | Upgrade
|
| Change in Accounts Receivable | - | 383.19 | -697.84 | -354.04 | -32.89 | Upgrade
|
| Change in Inventory | - | 6.07 | 85.47 | 5.58 | -1.14 | Upgrade
|
| Change in Accounts Payable | - | -237.08 | 132.56 | 124.13 | -59.93 | Upgrade
|
| Change in Other Net Operating Assets | - | -45.53 | 125.15 | -4.24 | -27.27 | Upgrade
|
| Operating Cash Flow | 544.6 | 766 | 191.08 | 76.02 | 76.62 | Upgrade
|
| Operating Cash Flow Growth | -28.90% | 300.87% | 151.35% | -0.78% | - | Upgrade
|
| Capital Expenditures | - | -470.82 | -229.61 | -249.52 | -416.56 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 21.5 | 0.38 | 0.13 | 0.13 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -8.5 | -2.76 | -0 | -0.95 | Upgrade
|
| Investment in Securities | - | -51 | -10 | - | - | Upgrade
|
| Other Investing Activities | -338.37 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -338.37 | -508.82 | -241.99 | -249.4 | -417.39 | Upgrade
|
| Long-Term Debt Issued | - | 1,597 | 1,566 | 1,182 | 1,105 | Upgrade
|
| Long-Term Debt Repaid | - | -2,656 | -1,330 | -951.39 | -705.91 | Upgrade
|
| Net Debt Issued (Repaid) | - | -1,059 | 235.88 | 230.49 | 399.11 | Upgrade
|
| Other Financing Activities | -232.21 | 803.01 | -157.93 | -69.64 | -47.12 | Upgrade
|
| Financing Cash Flow | -232.21 | -256.07 | 77.95 | 160.85 | 351.99 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 6.75 | 1.77 | - | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | - | -0 | - | - | Upgrade
|
| Net Cash Flow | -25.98 | 7.86 | 28.82 | -12.53 | 11.22 | Upgrade
|
| Free Cash Flow | 544.6 | 295.18 | -38.53 | -173.5 | -339.94 | Upgrade
|
| Free Cash Flow Growth | 84.50% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 17.55% | 10.24% | -1.45% | -8.06% | -18.15% | Upgrade
|
| Free Cash Flow Per Share | 5.92 | 3.21 | -0.42 | -1.89 | -3.69 | Upgrade
|
| Cash Interest Paid | - | 186.18 | 157.93 | 69.64 | 47.12 | Upgrade
|
| Levered Free Cash Flow | - | -150.59 | -107.96 | -281.13 | -392.73 | Upgrade
|
| Unlevered Free Cash Flow | - | -12.73 | -12.22 | -238 | -366.78 | Upgrade
|
| Change in Working Capital | - | 106.65 | -354.65 | -228.58 | -121.22 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.